Biased adrenergic agonists
US12024502B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 2, 2022 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Sep 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds, compositions, and methods for selecting targeting β2AR receptors. The compounds, compositions, and methods may be used in the treatment of obstructive lung diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.